| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
2,986,670 | 2,896,284 | 2,444,831 | 1,946,120 | 1,577,795 |
| Cost of Revenue
|
-729,560 | -619,067 | -472,012 | -365,598 | -281,123 |
|
Gross Profit
|
2,257,110 | 2,277,217 | 1,972,819 | 1,580,522 | 1,296,672 |
| Selling, General and Administrative Expenses
|
-1,178,084 | -1,162,755 | -1,082,333 | -968,248 | -863,142 |
|
Research and Development Expenses
|
-561,323 | -525,141 | -463,319 | -411,794 | -319,876 |
|
Operating Income/Expenses
|
-1,739,407 | -1,687,896 | -1,545,652 | -1,380,042 | -1,183,018 |
|
Total Operating Profit/Loss
|
517,703 | 589,321 | 427,167 | 200,480 | 113,654 |
| Total Net Finance Income/Expense
|
51,841 | 68,717 | 78,842 | 68,508 | 12,755 |
| Net Investment Income
|
-779 | 717 | 1,293 | -993 | 961 |
|
Non-Operating Income/Expenses, Total
|
51,062 | 69,434 | 80,135 | 67,515 | 13,716 |
|
Pretax Income
|
568,765 | 658,755 | 507,302 | 267,995 | 127,370 |
|
Provision for Income Tax
|
-239,374 | -215,451 | -114,226 | -89,055 | -73,985 |
|
Net Income from Continuing Operations
|
329,391 | 443,304 | 393,076 | 178,940 | 53,385 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
329,391 | 443,304 | 393,076 | 178,940 | 53,385 |
|
Net Income after Non-Controlling/Minority Interests
|
329,391 | 443,304 | 393,076 | 178,940 | 53,385 |
|
Net Income Available to Common Stockholders
|
329,391 | 443,304 | 393,076 | 178,940 | 53,385 |
|
Diluted Net Income Available to Common Stockholders
|
329,391 | 443,304 | 393,076 | 178,940 | 53,385 |
| Basic EPS
|
0.69 | 0.91 | 0.80 | 0.37 | 0.11 |
| Diluted EPS
|
0.69 | 0.90 | 0.78 | 0.36 | 0.11 |
|
Basic Weighted Average Shares Outstanding
|
472,965.25 | 488,278 | 490,879 | 489,261 | 486,937 |
|
Diluted Weighted Average Shares Outstanding
|
474,891 | 493,551 | 501,924 | 500,182 | 499,925 |
|
Reported Normalized Diluted EPS
|
1.66 | 1.77 | 1.66 | 1.26 | 1.04 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
516,924 | 590,038 | 428,460 | 199,487 | 114,615 |
|
EBITDA
|
643,395 | 705,822 | 515,950 | 279,905 | 169,040 |
|
Normalized EBITDA
|
1,069,263 | 1,196,449 | 1,010,649 | 771,526 | 667,682 |
|
Normalized Income
|
646,364.55 | 873,080 | 832,303 | 628,099 | 522,032 |
|
Total Unusual Items
|
425,868 | 490,627 | 494,699 | 491,621 | 498,642 |
|
Total Unusual Items Excluding Goodwill
|
425,868 | 490,627 | 494,699 | 491,621 | 498,642 |
|
Tax Effect of Unusual Items
|
108,894.45 | 160,435.03 | 111,307.28 | 163,218.17 | 128,699.50 |
12/31/2022 - 9/21/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade